Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study
25 juli 2014 bijgewerkt door: Salvador Sarró, MD
Schizophrenia is known to be associated with cognitive dysfunction which increasing evidence suggests has consequences for functional adaptation and which cause difficulties in social re-integration after hospitalization.
The investigators propose a large scale, multicentric study (7 centres from the Hermanas Hospitalarias del Sagrado Corazón de Jesús network) aimed at answering outstanding questions concerning the effectiveness of cognitive estimulation therapy for schizophrenic cognitive impairment.
Specifically, the study will examine a) issues related to the size of the effect compared to treatment as usual and compared to a control intervention; b) generalizability of improvement to cognitive function and social cognition in daily life; and c) the durability of therapeutic gains after the end of treatment.
192 patients with chronic schizophrenia will be randomly assigned to one of three treatment conditions: a computer- assisted cognitive estimulation program (n=64), non-structured time on computer (n=64) and treatment as usual (n=64).
A battery of neurocognitive tests of memory and executive function, including 'ecologically valid' measures, will be administered by blind evaluators at baseline, after 6 months of cognitive estimulation, and after 6 months follow-up.
Symptoms, social functioning and self-esteem will be also be assessed at baseline, after the treatment and at follow-up.
Studie Overzicht
Toestand
Voltooid
Conditie
Studietype
Ingrijpend
Inschrijving (Werkelijk)
130
Fase
- Niet toepasbaar
Contacten en locaties
In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.
Studie Locaties
-
-
-
Barcelona, Spanje, 08035
- FIDMAG Germanes Hospitalàries Research Foundation
-
-
Deelname Criteria
Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.
Geschiktheidscriteria
Leeftijden die in aanmerking komen voor studie
18 jaar tot 65 jaar (Volwassen, Oudere volwassene)
Accepteert gezonde vrijwilligers
Nee
Geslachten die in aanmerking komen voor studie
Allemaal
Beschrijving
Inclusion Criteria:
- schizophrenia or schizoaffective disorder fulfilling the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV) criteria diagnosis
- estimated premorbid intelligence quotient (IQ) in the normal range
- chronic illness (i.e. duration ≥two years)
- relative clinical stability (i.e. the patients had not experienced any recent exacerbation of symptoms).
Exclusion Criteria:
- history of brain trauma
- alcohol or substance abuse/dependence within the previous six months.
Studie plan
Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.
Hoe is de studie opgezet?
Ontwerpdetails
- Primair doel: Behandeling
- Toewijzing: Gerandomiseerd
- Interventioneel model: Parallelle opdracht
- Masker: Enkel
Wapens en interventies
Deelnemersgroep / Arm |
Interventie / Behandeling |
|---|---|
|
Experimenteel: Computer-assisted cognitive training
Patients in this arm of the trial carried out computerized online training drawn from the Feskits program (www.feskits.com),
chosen to have attention, memory and executive function components.
Specifically the sessions included the following exercises: sustained attention (4 minutes), attention/perception (5 minutes), working memory (8 minutes), auditory and visual memory (8 minutes), executive function (10 minutes), language (6 minutes), and games (4 minutes).
|
Treatment lasted six months.
The CRT and CC conditions consisted of biweekly sessions of 45 minutes.
Patients in both conditions trained in groups of up to 8, supervised by a single person.
The CRT and CC groups were scheduled at different times.
The same personnel supervised both treatment conditions.
All supervisors were trained by the coordinator of the study in the technical management of the two conditions.
Andere namen:
|
|
Actieve vergelijker: Computerized active condition
Patients allocated to this condition completed the same number of sessions as the cognitive training group but followed a computerized typing program (www.rapidtyping.com).
This had similar design characteristics to the CRT condition, in that it was hierarchically organized with exercise level of difficulty being adjusted to the individual's level of performance and feedback being given at the end of each exercise.
Additionally, patients in this condition played computerized games requiring typing (crosswords, word puzzles, etc) and were taught basic internet navigation by a supervisor.
Exposure to the computer was of equivalent duration to the CRT condition.
|
Treatment lasted six months.
The CRT and CC conditions consisted of biweekly sessions of 45 minutes.
Patients in both conditions trained in groups of up to 8, supervised by a single person.
The CRT and CC groups were scheduled at different times.
The same personnel supervised both treatment conditions.
All supervisors were trained by the coordinator of the study in the technical management of the two conditions.
Andere namen:
|
|
Placebo-vergelijker: Treatment as usual
Patients in this condition participated in their (individually variable) daily rehabilitative activities.
Patients allocated to the other two conditions also participated in these activities
|
TAU: Patients in this condition participated in their (individually variable) daily rehabilitative activities.
Patients allocated to the other two conditions also participated in these activities.
|
Wat meet het onderzoek?
Primaire uitkomstmaten
Uitkomstmaat |
Maatregel Beschrijving |
Tijdsspanne |
|---|---|---|
|
Memory test battery
Tijdsspanne: Six months
|
memory test battery Rivermead Behavioural Memory Test (RBMT)(Wilson, 1985) a memory test battery and the executive test battery, the Behavioural Assessment of the Dysexecutive Syndrome (BADS)(Wilson, 1996)
|
Six months
|
Medewerkers en onderzoekers
Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.
Sponsor
Medewerkers
Onderzoekers
- Studie directeur: Peter J McKenna, MD, FIDMAG Germanes Hospitalàries Research Foundation
- Hoofdonderzoeker: Jesus J Gomar, PhD, FIDMAG Germanes Hospitalàries Research Foundation
- Studie stoel: Edith Pomarol-Clotet, MD, PhD, FIDMAG Germanes Hospitalàries Research Foundation
Studie record data
Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.
Bestudeer belangrijke data
Studie start
1 januari 2010
Primaire voltooiing (Werkelijk)
1 december 2013
Studie voltooiing (Werkelijk)
1 februari 2014
Studieregistratiedata
Eerst ingediend
24 juli 2014
Eerst ingediend dat voldeed aan de QC-criteria
25 juli 2014
Eerst geplaatst (Schatting)
28 juli 2014
Updates van studierecords
Laatste update geplaatst (Schatting)
28 juli 2014
Laatste update ingediend die voldeed aan QC-criteria
25 juli 2014
Laatst geverifieerd
1 juli 2014
Meer informatie
Termen gerelateerd aan deze studie
Trefwoorden
Aanvullende relevante MeSH-voorwaarden
Andere studie-ID-nummers
- PR-2009-15
- PI09/90483 (Andere identificatie: Instituto de Salud Carlos III)
Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .